To ask the Secretary of State for Health if he will make a statement on the research being commissioned by his Department into the effectiveness of Betaferon (Beta-Interferon-lb) for relapsing-remitting and secondary progressive multiple sclerosis, specifying the length of the research period, its cost and with whom the research is to be placed. [67425]

Experts are still discussing the design of the proposed trial and no decision has therefore been made yet on its feasibility or value.